Financials
- Market Capitalization 228.11 M
- Employee 51
- Founded 2006
- CEO N/A
- Website www.protaratx.com
- Headquarter New York, United States
- FIGI BBG001ZLYSH5
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.79
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3487 | TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 14.10 USD | +3.75% | +12.26% | +38.78% | -6.06% | 241.83 M USD | ||
| 3491 | CLLS Cellectis S.A. - American Depositary Shares | 3.35 USD | -1.47% | +0.60% | +17.13% | +30.35% | 240.37 M USD | ||
| 3532 | RNA Atrium Therapeutics, Inc. - Common Stock | 13.32 USD | -2.35% | -2.92% | +16.33% | -81.06% | 227.85 M USD | ||
| 3541 | PRQR ProQR Therapeutics N.V. - Ordinary Shares | 2.13 USD | -6.99% | -11.98% | +23.12% | -4.91% | 224.42 M USD |